Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Evaluation of three fully-automated SARS-CoV-2 antibody assays

Detection Principle
ImmunoAssay-Antibody
Target
IgG and IgM
Testing Method Category
Other Immuno assay
Testing Method
SARS-CoV-2-ELISA (IgG) (Euroimmun), Elecsys anti-SARS-CoV-2 (Roche), SARS-CoV-2 Total (COV2T) (Siemens Healthineers)
Testing Method - Additional Info
comparison of ELISA, ECLIA and CLIA commercial tests
Reported Performance
Specificity: 100% ; sensitivity: 56.5% (0-6 days from+PCR, Siemens, Euroimmun), 65.2% 0-6 days after +PCR Roche), 90.3% (7-13 days after +PCR Siemens, Roche), 89.3% 7-13 days after +PCR Euroimmun), 97% (more than 14 days after +PCR Siemens), 89.4% (more than 14 days after +PCR Roche), 95.5% (more than 14 days after +PCR Euroimmun) ; remarks: using cut-off indeces some sensitivity values improve, but not specificity.
Sample Size
309 samples
Peer-reviewed
yes

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements